# ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study

> **NCT04609111** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Kyoto University, Graduate School of Medicine** · enrollment: 6002 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** No aspirin
- **DRUG:** 1-month DAPT

## Key facts

- **NCT ID:** NCT04609111
- **Lead sponsor:** Kyoto University, Graduate School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-01-29
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 6002 (ACTUAL)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04609111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04609111, "ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04609111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*